biomarker

Full title: The mapping of cortical activation by near-infrared spectroscopy might be a biomarker related to the severity of fibromyalgia symptoms Abstract The delta value of oxyhemoglobin (Δ-HbO) determined by functional near-infrared spectroscopy at prefrontal cortex (PFC) and motor cortex...

https://www.europeanreview.org/wp/wp-content/uploads/8519-8536.pdf See table 1 for protein vs HCs. Brought up as I read a post by @Andy about a possible study on salivary peptide fatigue testing in me/cfs. Could this be useful to find a biomarker in me/cfs?

https://otd.harvard.edu/news/nanoneedle-technology-licensed-for-early-disease-detection-biomarker-discov/

Abstract Neurological disorders, including neurodegenerative diseases, are collectively a major cause of death and disability worldwide. Whilst the underlying disease mechanisms remain elusive, altered mitochondrial function has been clearly implicated and is a key area of study in these...

Abstract Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a persistent and unexplained pathological state characterized by exertional and severely debilitating fatigue, with/without infectious or neuropsychiatric symptoms, and with a minimum duration of 6 consecutive months. Its...

Highlights • ME/CFS is characterized by skewed B cell receptor gene usage. • Upregulation of specific IGHV genes correlated to infection-related episodes at onset. • Plasmablasts of ME/CFS patients upregulated interferon response genes. • B cell receptor repertoire analysis can provide a useful...

Prototype. "Monitoring the effects of daily activities on the physiological responses of the body calls for wearable devices that can simultaneously track metabolic and haemodynamic parameters. Here we describe a non-invasive skin-worn device for the simultaneous monitoring of blood pressure...

Recursive ensemble feature selection provides a robust mRNA expression signature for myalgic encephalomyelitis/chronic fatigue syndrome https://www.nature.com/articles/s41598-021-83660-9

https://www.mdpi.com/2218-273X/11/2/185

Open access, https://www.mdpi.com/2077-0383/10/4/623/htm

https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-021-02713-9

I have a feeling that OMF might be closing in on a biomarker. But if there is a biomarker and it reflects something downstream, is it possible that the biomarker might not be useful in identifying treatments? Are there examples of other diseases where a biomarker was found, but it was not...

Full title: Are Circulating FGF21 and NT-proBNP promising novel biomarkers in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? https://www.liebertpub.com/doi/abs/10.1089/ars.2020.8230

https://www.nature.com/articles/s41598-020-77105-y

Google translated: The Canadian Press MONTREAL - A new test developed by Montreal researchers is expected to improve the diagnosis and treatment of patients with myalgic encephalomyelitis (ME), a condition better known as chronic fatigue syndrome. L'EM is currently diagnosed primarily by...

https://www.mdpi.com/journal/biomolecules/special_issues/Biomarkers_in_CFS https://twitter.com/BhupeshPrusty/status/1324791213745184769

Researchers at McMaster and Brock universities in Canada have developed a hand-held device that can provide rapid measurements of cancer biomarkers in blood samples.

https://euraxess.ec.europa.eu/jobs/545894

Paywall, https://content.iospress.com/articles/work/wor203177 Sci hub, https://sci-hub.tw/10.3233/WOR-203177

Free full text: https://bmccardiovascdisord.biomedcentral.com/articles/10.1186/s12872-020-01465-6